Biotechnology R&D expenditure as percent of BERD in select countries 2022

Published by
Matej Mikulic,
Dec 19, 2024

This statistic shows the research and development spending as a percentage of business expenditure of biotechnology companies in selected countries in 2022 (or 2023, if available). As of that year, biotechnology companies in the U.S. spent nearly 17 percent of business expenditures on R&D.

Biotech R&D expenditure as a percent of BERD in selected countries in 2022

CharacteristicR&D spending as percentage of BERD
Lithuania (2023) 19.8%
United States 16.9%
Spain 11.2%
France 10.8%
Norway 7.5%
Estonia 5.7%
Canada 5.2%
Austria (2023) 4.7%
Germany (2023) 4.5%
Latvia 4.5%
Italy 3.8%
Portugal 3.6%
Slovenia 2.5%
Showing entries 1 to 13 (17 entries in total)
Created with Highcharts 7.2.2R&D spending as percentage of BERD19.8%19.8%16.9%16.9%11.2%11.2%10.8%10.8%7.5%7.5%5.7%5.7%5.2%5.2%4.7%4.7%4.5%4.5%4.5%4.5%3.8%3.8%3.6%3.6%2.5%2.5%2.3%2.3%2.2%2.2%2.1%2.1%1.7%1.7%Lithuania (2023)United StatesSpainFranceNorwayEstoniaCanadaAustria (2023)Germany (2023)LatviaItalyPortugalSloveniaCzechia (2023)KoreaPolandJapan
0%1%2%3%4%5%6%7%8%9%10%11%12%13%14%15%16%17%18%19%20%21%22%

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2024

Region

Worldwide, OECD

Survey time period

2022 and 2023

Supplementary notes

Business Enterprise Expenditure on R&D -- BERD. For some countries, 2023 figures were already available.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Medical biotech industry "

Other statistics that may interest you Medical biotech industry

Global overview

7

Research & development

6

R&D country comparison

3

Products

4

Funding/M&A/IPOs

5

Focus: U.S. companies

6

Focus: RNA/mRNA

3

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Biotech drugsGlobal pharmaceutical industryCancer in the U.S.AmgenCoronavirus (COVID-19) vaccines and treatments
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.